Search results for “Myelogenous Leukemias” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 162 patents, we discovered top 81 key players by total patent application. Amgen, Inc., Imago BioSciences, Inc., GlycoMimetics, Inc. are dominant in this area. They take 17.90% of the total patent filing.
Amgen, Inc.
California, United States
Patent: 16
Imago BioSciences, Inc.
California, United States
Patent: 7
GlycoMimetics, Inc.
United States
Patent: 6
Eli Lilly & Co.
Indiana, United States
Patent: 5
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 4
Glycotope GmbH
Berlin, Germany
Patent: 4
Amgen Research (Munich) GmbH
Hessen, Germany
Patent: 4
Guangzhou Zhirui Pharmaceutical Technology Co Ltd.
Guangdong Sheng, China
Patent: 4
Institute For Research In Biomedicine
Switzerland
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 4 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, SERVIER PHARMA LLC, Forty Seven, Inc. are active in this area.
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
STARTUP
SERVIER PHARMA LLC
Massachusetts, United States
Patent: 1
STARTUP
Forty Seven, Inc.
California, United States
Patent: 1
STARTUP
Clear Creek Bio, Inc.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 111 patents applied in the last 5 years. We discover 60 most active companies in this area. The fast-growing Amgen, Inc., GlycoMimetics, Inc., Dana-Farber Cancer Institute, Inc. take 19.82% of patent filing during this period.
Amgen, Inc.
California, United States
Patent: 11
GlycoMimetics, Inc.
United States
Patent: 6
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 5
Guangzhou Zhirui Pharmaceutical Technology Co Ltd.
Guangdong Sheng, China
Patent: 4
Imago BioSciences, Inc.
California, United States
Patent: 4
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 3
University of Bern
Bern, Switzerland
Patent: 3
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Eli Lilly & Co.
Indiana, United States
Patent: 3
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 111 patents in last 5 years, we discover 46 new entrants. GlycoMimetics, Inc., Dana-Farber Cancer Institute, Inc., Guangzhou Zhirui Pharmaceutical Technology Co Ltd. are the most active new entrants in this area.
GlycoMimetics, Inc.
United States
Patent: 6
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 5
Guangzhou Zhirui Pharmaceutical Technology Co Ltd.
Guangdong Sheng, China
Patent: 4
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Actinium Pharmaceuticals, Inc.
New York, United States
Patent: 3
University of Bern
Bern, Switzerland
Patent: 3
Hanmi Pharmaceutical Co., Ltd.
South Korea
Patent: 3
Pusan National University Industry-University Cooperation
South Korea
Patent: 2
Flash Therapeutics LLC
Massachusetts, United States
Patent: 2
FUJIFILM Corp.
Tokyo-to, Japan
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 33 patents, we discovered top 15 universities and scientific research institutions by total patent application. Yale University, University of Bern, Thomas Jefferson University are dominant in this area. They take 36.36% of the total patent filing.
Yale University
Connecticut, United States
Patent: 4
University of Bern
Bern, Switzerland
Patent: 3
Thomas Jefferson University
Pennsylvania, United States
Patent: 2
The University of Chicago
Illinois, United States
Patent: 1
University of Rochester
New York, United States
Patent: 1
University of British Columbia
British Columbia, Canada
Patent: 1
Vanderbilt University
Tennessee, United States
Patent: 1
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 1
The Rockefeller University
New York, United States
Patent: 1
University of Strasbourg
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: